OneChain Immunotherapeutics is a spin-off of the Josep Carreras Leukemia Research Institute and ICREA, which aims to develop CAR-T candidates against different antigens as a treatment against hematological neoplasms, based on the research of Dr. Pablo MenГ©ndez.